Markets.News
A recent study published in Critical Care Explorations sheds light on the advantages of using a single-prong cannula design for hypercapnic patients. The research, released on May 20, 2025, in Exeter, New Hampshire, emphasizes the benefits of this design in providing respiratory support. Vapotherm, Inc., a renowned company specializing in mask-free noninvasive respiratory support, unveils these findings. This study could potentially revolutionize the treatment for hypercapnic patients and enhance their overall care, impacting a significant number of individuals struggling with respiratory issues.